William W. Bachovchin | |
|---|---|
| Nationality | American |
| Occupation(s) | Chemist/chemical biologist, academic, and researcher |
| Awards |
|
| Academic background | |
| Education | |
| Alma mater | |
| Academic work | |
| Institutions | Tufts University School of Medicine |
William W. Bachovchin is an American chemist/chemical biologist, academic and researcher. He is a professor of Molecular and Chemical Biology at Tufts University School of Medicine,[1] and the founder of three biopharmaceutical companies: Point Therapeutics, Arisaph Pharmaceuticals, and Bach BioSciences.[2]
Bachovchin has published over 100 articles, and is the inventor of 58 issued US patents.[3] His research has focused primarily on a family of proteolytic enzymes known as the serine proteases and has ranged from studies of their catalytic mechanisms at the molecular level, to identifying their biological functions, to the design and development of drugs targeting them. His work has made extensive use of NMR spectroscopy, mutagenesis, chemical synthesis, and in vivo testing of drug candidates in animal models.[4]